a developer of drugs for the treatment of anemia and vascular diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, AKBA has been loosely correlated with INZY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AKBA jumps, then INZY could also see price increases.
Ticker / NAME | Correlation To AKBA | 1D Price Change % | ||
---|---|---|---|---|
AKBA | 100% | -9.03% | ||
INZY - AKBA | 43% Loosely correlated | -5.60% | ||
ABCL - AKBA | 38% Loosely correlated | -2.34% | ||
CDXC - AKBA | 38% Loosely correlated | -4.93% | ||
SEER - AKBA | 37% Loosely correlated | -0.60% | ||
BEAM - AKBA | 36% Loosely correlated | -8.55% | ||
More |
Ticker / NAME | Correlation To AKBA | 1D Price Change % |
---|---|---|
AKBA | 100% | -9.03% |
drugs theme (265 stocks) | 41% Loosely correlated | +5.37% |
diseases theme (42 stocks) | 40% Loosely correlated | +1.03% |
biotechnology theme (248 stocks) | 38% Loosely correlated | +5.56% |
vascular theme (5 stocks) | 25% Poorly correlated | +1.81% |
Pharmaceuticals theme (328 stocks) | 25% Poorly correlated | +0.11% |